A Role for Renin in Rebound Hypertension and Encephalopathy after Infusion of Saralasin Acetate (Sar1-Ala8-Angiotensin II)

Hans J. Keim; Jan I.M. Drayer; David B. Case; Jorge A. Lopez-Ovejero; John M. Wallace; Michael A. Weber; John H. Laragh

doi:10.1056/nejm197611182952106

Back to search

A Role for Renin in Rebound Hypertension and Encephalopathy after Infusion of Saralasin Acetate (Sar¹-Ala⁸-Angiotensin II)

Hans J. Keim, Jan I.M. Drayer, David B. Case, Jorge A. Lopez-Ovejero, John M. Wallace

DOI: 10.1056/nejm197611182952106

New England Journal of Medicine

Data up to Jan 2025

Published1976

Citations41

References7

Fields

Medicine Internal medicine Endocrinology

Total Citations Per Year

Abstract

References (7)

Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” Hypertension

1975 • 279 citations

The effect of intracarotid epinephrine, norepinephrine, and angiotensin on the regional cerebral blood flow in man

1972 • 253 citations

Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin II, for evaluating the renin and sodium factors in hypertensive patients

1976 • 174 citations

Upper Limit of Autoregulation of Cerebral Blood Flow in the Baboon

1974 • 173 citations

Renin, angiotensin and hypertensive vascular damage: A review

1973 • 115 citations

Saralasin bolus test

1975 • 47 citations

Radioimmunoassay and pharmacokinetics of saralasin in the rat and hypertensive patients

1975 • 44 citations

Cited By (0)

Loading...